...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Biotage Announces an Easy, Cost-Effective Approach to the Analysis of Ethyl Glucuronide (EtG) in Urine for Clinical and Forensic Toxicology Laboratories

| Print |
Thursday, 16 December 2010 16:00 (UTC + 1)

biotage_logo

Uppsala, Sweden, December 16, 2010 / b3c newswire / – Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, introduced a new sample preparation application note for the extraction of ethyl glucuronide from urine by LC-MS.

 

EtG can be detected at very low levels and being a metabolite it is useful in distinguishing between ingested ethanol and that which is absorbed through the skin from ethanol containing products such as alcohol based hand washes. Rapid and reliable methods with robust extraction protocols are essential for analysis and quantitation of EtG from various matrices.

 

Advances in the manufacture of polymeric stationary phases and the recent release of EVOLUTE® AX, a mixed-mode ion exchange product, have allowed for the development of a more robust, cost-effective procedure. The protocol was developed on 96-well plates for high-throughput with volumes outlined for scale-up to cartridges in manual or automated systems.

 

EVOLUTE AX sample preparation products are available in a range of standard configurations and 2 different particle sizes (30 μm and 50 μm) to suit a wide variety of applications. The mixed-mode sorbent chemistry and optimized pore size minimizes retention of high molecular weight matrix components present in the biological fluid samples. Interferences including proteins, salts, non-ionizable molecules and phospholipids are removed during the interference elution step, thereby ensuring extremely clean extracts.

 

Biotage sample preparation products are supported by a wealth of knowledge and experience in method development and trouble shooting. “Clinical laboratories face unique challenges in developing new LC-MS assays. By offering solid chemistry through the EVOLUTE family, and simplified techniques for sample prep, we can help these labs build robust procedures quickly”, says Elena Gairloch, Market Manager. “We realize that labs have many considerations including processing stations and work load. By offering solutions in an array of formats, we can make these solutions accessible to almost every lab. The EtG application note is another example of how using a cleaner polymeric SPE sorbent can make developing modern methods easier.”

For more information regarding the complete line of Biotage products for sample preparation, visit http://www.biotage.com/


 

About Biotage - www.biotage.com 
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.


 

For further press information at Biotage please contact:
Rob Thompson
Director of Marketing Communications
10430 Harris Oaks Blvd., Suite C
Charlotte, NC USA 28269
Tel: +1 704 654 4847
Fax: +1 704 654 4917
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it